Literature DB >> 1455088

An overview of potential applications of heparin in vitreoretinal surgery.

M S Blumenkranz1, M K Hartzer, D Iverson.   

Abstract

Heparin is a naturally occurring complex polysaccharide with properties that lend themselves to the potential treatment of proliferative ocular disorders. The biochemistry of heparin and its effects on the eye and cultured ocular cells under varied experimental conditions are discussed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1455088     DOI： 10.1097/00006982-199212031-00015

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


  7 in total

1.  Effect of intraoperative 5-fluorouracil and low molecular weight heparin on the outcome of high-risk proliferative vitreoretinopathy.

Authors:  Sunil Ganekal; Syril Dorairaj
Journal:  Saudi J Ophthalmol       Date:  2014-03-21

2.  Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

Authors:  R G Williams; S Chang; M R Comaratta; G Simoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 3.  [Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].

Authors:  F Schaub; A M Abdullatif; S Fauser
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

4.  Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis.

Authors:  Chen Chen; Peng Chen; Xia Liu; Hua Li
Journal:  Front Med (Lausanne)       Date:  2021-11-30

Review 5.  Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.

Authors:  Stavros N Moysidis; Aristomenis Thanos; Demetrios G Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-25       Impact factor: 4.711

Review 6.  Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.

Authors:  Francesco Morescalchi; Sarah Duse; Elena Gambicorti; Mario R Romano; Ciro Costagliola; Francesco Semeraro
Journal:  Mediators Inflamm       Date:  2013-09-30       Impact factor: 4.711

7.  Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.

Authors:  Friederike Schaub; Robert Hoerster; Petra Schiller; Moritz Felsch; Daria Kraus; Marouan Zarrouk; Bernd Kirchhof; Sascha Fauser
Journal:  Trials       Date:  2018-07-16       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.